This confirms the success observed in a preclinical experimental autoimmune uveitis model in mice.54 For such reasons, anakinra may be considered as an alternative biologic agent in patients with JIA-associated uveitis refractory to anti-TNF therapy. This evidence concerns the gene TNF and uveitis.